Stock USRM U.S. STEM CELL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News U.S. Stem Cell, Inc.

Equities

USRM

US90350U1007

Market Closed - OTC Markets
Other stock markets
 12:01:45 2024-06-24 EDT 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for U.S. Stem Cell, Inc. 0.00% 0.00%
2023 U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
2023 U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
U.S. STEM CELL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt
CI
NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS
AQ
U.S. Stem Cell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
U.S. STEM CELL, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations
AQ
NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS
AQ
U.S. Stem Cell, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
U.S. STEM CELL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt
CI
U S Stem Cell : Material Event - Form 8-K/A
PU
U.S. STEM CELL, INC. Other Events (form 8-K/A)
AQ
U S Stem Cell : Mark Borman appointed Chairman of the Board of USRM
PU
U.S. STEM CELL, INC. : Other Events (form 8-K)
AQ
U.S. Stem Cell, Inc. Announces Management Changes
CI
NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS
AQ
U.S. Stem Cell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
U S Stem Cell : USRM to Focus on Animal Health and Lead Pet-Care Innovation
PU
U S Stem Cell : NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. USRM Stock
  4. News U.S. Stem Cell, Inc.